These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22414588)

  • 21. Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa.
    Palmer M; Chersich M; Moultrie H; Kuhn L; Fairlie L; Meyers T
    AIDS; 2013 Mar; 27(5):781-5. PubMed ID: 23169331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stavudine toxicity in adult longer-term ART patients in Blantyre, Malawi.
    van Oosterhout JJ; Mallewa J; Kaunda S; Chagoma N; Njalale Y; Kampira E; Mukaka M; Heyderman RS
    PLoS One; 2012; 7(7):e42029. PubMed ID: 22848696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of stavudine-based antiretroviral therapy on the severity of polyneuropathy in HIV/AIDS patients: a preliminary report from Zaria, Northern Nigeria.
    Obiako OR; Abdu-Aguye I; Ogunniyi A
    West Afr J Med; 2011; 30(5):354-8. PubMed ID: 22752824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study.
    Podlekareva D; Grint D; Karpov I; Rakmanova A; Mansinho K; Chentsova N; Zeltina I; Losso M; Parczewski M; Lundgren JD; Mocroft A; Kirk O;
    HIV Med; 2015 Oct; 16(9):533-43. PubMed ID: 25988795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
    Cherry CL; Affandi JS; Imran D; Yunihastuti E; Smyth K; Vanar S; Kamarulzaman A; Price P
    Neurology; 2009 Jul; 73(4):315-20. PubMed ID: 19636052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings.
    Makinson A; Moing VL; Kouanfack C; Laurent C; Delaporte E
    Expert Opin Drug Saf; 2008 May; 7(3):283-93. PubMed ID: 18462186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stavudine-associated peripheral neuropathy in zidovudine-naïve patients: effect of stavudine exposure and antiretroviral experience.
    Scarsella A; Coodley G; Shalit P; Anderson R; Fisher RL; Liao Q; Ross LL; Hernandez JE
    Adv Ther; 2002; 19(1):1-8. PubMed ID: 12008857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients. The STADI Group.
    Reynes J; Denisi R; Massip P; Izopet J; Pellegrin I; Segondy M
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):103-5. PubMed ID: 10534154
    [No Abstract]   [Full Text] [Related]  

  • 29. Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues.
    Famularo G; Moretti S; Marcellini S; Trinchieri V; Tzantzoglou S; Santini G; Longo A; De Simone C
    AIDS; 1997 Feb; 11(2):185-90. PubMed ID: 9030365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal lactate levels from routine point-of-care monitoring in adult Malawian antiretroviral therapy patients: associations with stavudine toxicities.
    Chagoma N; Mallewa J; Kaunda S; Njalale Y; Kampira E; Mukaka M; Heyderman RS; van Oosterhout JJ
    Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):615-9. PubMed ID: 23926161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stavudine toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line antiretroviral treatment in Uganda.
    Castelnuovo B; Kiragga A; Kamya MR; Manabe Y
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):59-63. PubMed ID: 20861741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Ciaffi L; Kouanfack C; Mougnutou R; Nkoué N; Calmy A; Koulla-Shiro S; Delaporte E
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):393-9. PubMed ID: 18327976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
    Evans D; Takuva S; Rassool M; Firnhaber C; Maskew M
    J Neurovirol; 2012 Jun; 18(3):162-71. PubMed ID: 22528477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.
    Boulle A; Orrel C; Kaplan R; Van Cutsem G; McNally M; Hilderbrand K; Myer L; Egger M; Coetzee D; Maartens G; Wood R;
    Antivir Ther; 2007; 12(5):753-60. PubMed ID: 17713158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa.
    Rosen S; Long L; Fox M; Sanne I
    J Acquir Immune Defic Syndr; 2008 Jul; 48(3):334-44. PubMed ID: 18545151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
    Maritz J; Benatar M; Dave JA; Harrison TB; Badri M; Levitt NS; Heckmann JM
    Muscle Nerve; 2010 May; 41(5):599-606. PubMed ID: 20229576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse drug reactions associated with antiretroviral therapy in South Africa.
    Birbal S; Dheda M; Ojewole E; Oosthuizen F
    Afr J AIDS Res; 2016 Sep; 15(3):243-8. PubMed ID: 27681148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy.
    Westreich DJ; Sanne I; Maskew M; Malope-Kgokong B; Conradie F; Majuba P; Funk MJ; Kaufman JS; Van Rie A; Macphail P
    Clin Infect Dis; 2009 Jun; 48(11):1617-23. PubMed ID: 19385733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children.
    Buck WC; Kabue MM; Kazembe PN; Kline MW
    J Int AIDS Soc; 2010 Aug; 13():31. PubMed ID: 20691049
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Gaff J; Octaviana F; Pillay P; Mbenda HGN; Ariyanto IA; Gan JA; Cherry CL; Kamerman P; Laws SM; Price P
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.